Please login to the form below

Not currently logged in
Email:
Password:

research spend

This page shows the latest research spend news and features for those working in and with pharma, biotech and healthcare.

German pharma market to edge up to $65bn by 2020

German pharma market to edge up to $65bn by 2020

Germany's pharmaceutical market will only 'crawl' forward for the rest of the decade as the country looks to reduce spend on new medicines, according to research and consulting firm GlobalData.

Latest news

  • Selfie campaign boosts cancer funds Selfie campaign boosts cancer funds

    Without it we wouldn't have received over £140, 000 to spend on life-saving research.”. ... Cancer Research UK said it had had more than 800, 000 text donations in the latter half of last week, raising close to £1.5m.

  • Pharma's return on R&D spend continues to slide Pharma's return on R&D spend continues to slide

    approval. "The largest pharmaceutical companies have performed well in terms of bringing new products to market but are struggling with diminishing returns on investment," said the two research firms in a ... statement, adding that while R&D spend has

  • European R&D investment European R&D investment "stagnating"

    Report says health research spend was flat in 2011.  . Spending in the EU on health-related R&D tailed off in 2011 after decades of annual increases, according to a new ... Commenting on the new report, Jane Griffiths - who is the chair of Janssen's

  • Patient-centricity for pharma marketers Patient-centricity for pharma marketers

    It's difficult to empathise. Marketers must spend time in immersive research, ie, in the day to day lives of patients. ... 5.Be better than before. How much research is done to improve patients' experience of existing products?

  • European pharma patent court deal sealed European pharma patent court deal sealed

    The agreement will help our inventors who can in future spend more time on research and development, producing new ideas and less time filling in forms and defending their patents in

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The diabetic population shows no sign of reducing any time soon, with research suggesting that the number of diabetics in Europe is expected to grow from 58 million today to 67 ... biosimilar and the promise of Mylan’s pipeline, which is fuelled by an

  • Turkey's pharma market is ripe for profitability Turkey's pharma market is ripe for profitability

    During profitable years, Turkish pharmaceutical manufacturers were earning so much money from selling generics that they didn't spend time on research.”. ... Kemal Yildiz, Berko Pharmaceuticals argues that this has influenced Turkish pharmaceutical

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics